Varlilumab是一种单克隆抗体,设计用于实体瘤和血液恶性肿瘤的免疫治疗。它是一种抗CD27抗体,有助于激活T细胞。 伐利尤单抗生物仿制药-研究级该产品同种型对照:Bulk Human IgG4 Isotype Control (IB4) [ICH2257] 缓冲液:ICH3002 浓度:5mg/ml 纯度:>95% by SDS-PAGE 内毒素:≤ 1.0 EU/mg as determined by the LAL method 制剂:Sterile, preservative-free, solution in PBS. BSA and Azide free.